9:50am – 10:25am
Social media is a driving and dynamic force in healthcare — except for those companies regulated by the FDA. But, nature abhors a vacuum, and the lack of responsible players sharing important information is a disservice to the public health. “In compliance” and “in the best interests of the public health” needn’t be mutually exclusive. It’s time for savvy pharma marketers to “seize the day”.
In this session, you will learn:
- What the two FDA guidances on social media really mean?
- Why companies are so frightened about social media (beyond adverse event reporting)?
- How regulated industry can be the first among equals in social media?
Peter Pitts, President
CENTER FOR MEDICINE IN THE PUBLIC INTEREST